Chiesi Group and VoiceMed launch pilot to advance early detection of chronic respiratory diseases through vocal biomarkers
January 13, 2026
Chiesi Group and VoiceMed have launched a six-month pilot to test smartphone-based vocal biomarkers for early detection of chronic respiratory diseases, focusing on COPD.